Drug Profile
Lorglumide
Alternative Names: CR 1392; CR 1409Latest Information Update: 06 Jun 2001
Price :
$50
*
At a glance
- Originator Rottapharm
- Class Basic amino acids; Diamino amino acids; Small molecules
- Mechanism of Action Cholecystokinin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Biliary dyskinesia; Cancer; Pancreatitis
Most Recent Events
- 06 Jun 2001 Discontinued-Preclinical for Cancer in Italy (Unknown route)
- 01 Dec 1994 Preclinical development for Cancer in Italy (Unknown route)